Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page
- Check3 days agoChange DetectedA recruitment status line signaling no longer looking for participants was added, and new sections for How to Read a Study Record, Common Questions, and How to Join a Study were introduced. The Intervention/Treatment heading was standardized, and the page revision was updated to v3.6.0 (replacing v3.5.5).SummaryDifference0.4%

- Check11 days agoChange DetectedThe page now displays Revision: v3.5.5 at the bottom, replacing v3.5.4 to reflect a deployment update. No study content or data are changed.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing Revision: v3.5.3. This indicates a minor update to the page version without altering study details or results.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page’s version/revision label was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the study record content.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check89 days agoChange DetectedA new site revision label 'Revision: v3.5.0' is displayed and the previous 'Revision: v3.4.3' label is removed.SummaryDifference0.0%

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.